CORONARY INTERVENTIONS

ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis

EuroIntervention 2016;12:e1395-e1403 published online ahead of print December 2015 published online e-edition December 2016. DOI: 10.4244/EIJY15M12_04

Martin Orban
Martin Orban1*, MD; Tobias Limbourg2, PhD; Franz-Josef Neumann3, MD; Miroslaw Ferenc3, MD; Hans-Georg Olbrich4, MD; Gert Richardt5, MD; Marcus Hennersdorf6, MD; Klaus Empen7, MD; Georg Fuernau8, MD; Steffen Desch9, MD; Ingo Eitel9, MD; Rainer Hambrecht10, MD; Janine Pöss9, MD; Steffen Schneider2, PhD; Gerhard Schuler8, MD; Karl Werdan11, MD; Uwe Zeymer2, MD; Holger Thiele9, MD; Jörg Hausleiter1, MD
1. Ludwig-Maximilians-Universität, Munich and German Heart Center Munich, Munich, Germany; 2. Klinikum Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen, Germany; 3. Heart Center Bad Krozingen, Bad Krozingen, Germany; 4. Asklepios Clinic La

Aims: The aim of this post hoc subgroup analysis of the Intraaortic Balloon Pump in Cardiogenic Shock II trial was to compare the clinical outcome of patients tr

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clopidogreldual antiplatelet therapyout of hospital cardiac arrestp2y<span class="indice">12</span> receptor inhibitorsprasugrelticagrelortherapeutic hypothermia
Coronary interventionsInterventions for heart failureSTEMINSTEMIAcute heart failureAdjunctive pharmacotherapyAdjunctive pharmacotherapyAdjunctive pharmacotherapy
Read next article
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Latest news